Detection of and Characteristics of Disease Progression in Children with CKD

Study Dates: 2022 - Unknown
Principal Investigator: Hovinga, Collin , Breitenstein, Stefanie
Affiliation: Institute for Advanced Clinical Trials for Children , Bayer AG
Sponsor Site: PEDSnet Data Coordinating Center
PEDSnet Study ID: 2020.HOVC.IND.DCC.245

Study to inform the design of a possible clinical trial in children with chronic kidney disease.

No files are available for download.

Tags

Funding

This research was made possible through the generous support of Institute for Advanced Clinical Trials for Children, Bayer AG.

Creative Commons license

a CC-BY 4.0 Attribution license.

Except where otherwised noted, this item's license is described as a CC-BY 4.0 Attribution license.

Publisher

PEDSnet

Project Description

The purpose of this study was to inform the design of a possible clinical trial in children with chronic kidney disease.

Study Aims

Identify a population of children ages 6 months to less than 18 years-old with chronic kidney disease defined by an eGFR in the range 30-89 ml/min and then, and
Characterize their longitudinal changes in kidney function over time in order to identify a sub-group of rapid progressors.

Clinical Subject Headings